Alabama Alaska Arizona Arkansas California Colorado Florida Georgia Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2529 blog entries.

Nebraska

The Department of Health and Human Services (DHHS) sent its fourth issuance of Summer Electronic Benefit Transfer (EBT) benefits to households with eligible school-age children. A one-time payment of $120 to purchase groceries will be issued for each eligible child, intended to cover the three summer months at $40 a month. Summer EBT benefits can be used to purchase food at grocery stores, online food retailers and farmer’s markets that accept SNAP EBT. 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2025-07-11T09:06:09-04:00July 11, 2025|Nebraska|

Nevada

Gov. Joe Lombardo (R) vetoed AB 411, legislation that would have allowed a prescriber to request that the prescription label for mifepristone, misoprostol or their generic alternatives would indicate the name of the prescribing health care practice instead of the name of the prescribing practitioner. 

Also in Nevada, the Board of Pharmacy posted the agenda and meeting materials for the July 16 and 17 meeting in Las Vegas. 

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2025-07-11T09:05:39-04:00July 11, 2025|Nevada|

New Jersey

At its June 25 public meeting, the Board of Pharmacy issued a temporary waiver of the 72-hour dispensing limit in N.J.A.C. 13:39-7.4(a) to allow for dispensing of up to a 10-day emergency supply of non-controlled substance medications for Rite Aid patients affected by the closure of their pharmacies. This waiver may be used by any state-registered pharmacy but applies only to prescriptions for former Rite Aid patients. The waiver will be in effect until October 1. To satisfy the requirement in N.J.A.C. 13:39-7.4(a)1, after obtaining suitable identification from the patient or caregiver, the pharmacist may rely upon information on a prescription bottle containing a Rite Aid label. Pharmacists are expected to comply with all documentation requirements in the Board’s existing rules.

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2025-07-11T09:05:11-04:00July 11, 2025|New Jersey|

New York

Effective July 15, NYRx, the Medicaid Pharmacy Program, will accept electronic prior authorization (ePA) requests via CoverMyMeds® in addition to the current phone and fax submission methods. 

To learn more about CoverMyMeds® Electronic Prior Authorization for Medicaid Prescribers, please attend one of the webinars which occur on Tuesdays and Thursdays from 12:00 pm – 1:00 pm ET. View the calendar with upcoming dates and registration links. 

The NYRx Education & Outreach Call Center is available by phone at 1-833-967-7310 or by email at NYRxEO@primetherapeutics.com from 8:00 am to 5:00 pm ET, Monday through Friday, excluding holidays.  

In addition, the following changes will be made to the Dispense Brand Name Drug When Less Expensive Than the Generic Program:  

"NuvaRing® will be REMOVED from the program, as the new manufacturer of NuvaRing® does not participate in the Medicaid Drug Rebate Program (MDRP)." In conformance with State Education Law, a pharmacist shall dispense a less expensive, therapeutically equivalent drug containing the same active ingredients, dosage form and strength as the drug prescribed/ordered. This includes substituting the brand name drug when NYRx has determined it to be the less expensive alternative for the patient. Brand name drugs included in this program:  

  • Do not require "Dispense as Written" (DAW) or "Brand Medically Necessary" on the prescription. 
  • Have a generic copayment. 
  • Are paid at the Brand Name Drug reimbursement rate or usual and customary price, whichever is lower (SMAC/FUL are not applied). 
  • Do not require a new prescription if the drug is removed from this program. 

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

2025-07-11T09:04:41-04:00July 11, 2025|New York|

North Carolina

SB 479, the Supporting Community Retail Pharmacies and Improving Transparency (SCRIPT) Act, has been signed by Gov. Josh Stein (D). Effective upon signature, the bill extends the current Medicaid reimbursement paid to pharmacies from July 1, 2026, to June 30, 2031. Additionally, it makes sweeping reforms to pharmacy and prescription drug regulations by expanding patient choice; increasing transparency and oversight of PBMs and pharmacy services administrative organizations (PSAOs); strengthening fair reimbursement and network practices; mandating drug price disclosures; and enhancing consumer protections across the state.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2025-07-11T09:03:54-04:00July 11, 2025|North Carolina|

Ohio

Sen. Mark Romanchuk (R) has introduced SB 230, legislation permitting pharmacists to test and treat patients for flu, strep, COVID-19, RSV and other respiratory conditions as specified in future rules adopted by the Board of Pharmacy. The Legislature has adjourned for the summer, so we do not expect any action on the bill before the fall.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2025-07-11T09:03:22-04:00July 11, 2025|Ohio|

Oklahoma

The US Supreme Court has declined to review the PCMA v. Mulready case, marking a significant setback for efforts to protect patients and pharmacies from harmful practices by PBMs. This decision upholds the 10th Circuit’s ruling, which struck down key provisions of the state’s Patient’s Right to Pharmacy Choice Act on the grounds that they are preempted by ERISA and Medicare Part D. As a result, the state now faces limited options for safeguarding pharmacies and ensuring patient access to the medications they need.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2025-07-11T09:02:50-04:00July 11, 2025|Oklahoma|

Oregon

The Prescription Drug Affordability Board posted its draft agenda and meeting materials for the July 16 meeting. Register here in advance.  

Also in Oregon, the Board of Pharmacy is proposing to adopt the following rules:  

The July 22 Rulemaking Hearing will be held virtually via Teams and begins at 9:30 am. If you wish to provide virtual oral testimony during the hearing, please complete and submit the Rulemaking Hearing Testimony Sign Up Form on the board's website. You may also sign up by submitting your first and last name, email address and which rule(s) you would like to comment on to pharmacy.rulemaking@bop.oregon.gov no later than 9:00 am on July 22. You will receive a confirmation email and a calendar invitation to join the virtual hearing. Written comments must be received by 4:30 pm on July 22. Submit written comments to pharmacy.rulemaking@bop.oregon.gov. If you would like to listen to the rulemaking hearing, join the virtual Teams meeting or call: (503) 446-4951 Phone Conference ID: 429 564 160#. Email all rulemaking inquiries to pharmacy.rulemaking@bop.oregon.gov. 

Also in Oregon, the Board of Pharmacy is proposing to adopt the following rule: Div 110 – Licensee & Registrant Fee Increase. The August 21 Rulemaking Hearing will be held virtually via Teams and begins at 9:30 am. If you wish to provide virtual oral testimony during the hearing, please complete and submit the Rulemaking Hearing Testimony Sign Up Form on the board's website. You may also sign up by submitting your first and last name, email address and which rule(s) you would like to comment on to pharmacy.rulemaking@bop.oregon.gov no later than 9:00 am on August 21. You will receive a confirmation email and a calendar invitation to join the virtual hearing. Written comments must be received by 4:30 pm on August 21. Submit written comments to pharmacy.rulemaking@bop.oregon.gov. If you would like to listen to the rulemaking hearing, join the virtual Teams meeting or call: (503) 446-4951 Phone Conference ID: 340 244 93 #. Email all rulemaking inquiries to pharmacy.rulemaking@bop.oregon.gov. 

Finally in Oregon, the state's Special Supplemental Nutrition Program for Women, Infants and Children (WIC) updated its food package effective July 1 for participants to enhance nutrition and expand choice for families statewide. The state's WIC participants may shop for food on the updated list using their benefit card at any of the WIC-authorized grocery stores across the state. Enhancements to the WIC Food Package include more fruits and vegetables; a wider variety of protein and plant-based options; more cheese varieties; new yogurt brands with reduced added sugar; new plant-based milks; and new nut and seed butters.

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

For more information, please contact NACDS’ Mike Sargent at 207-272-6435.

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

For more information, contact NACDS’ Mary Staples at 817-442-1155.

2025-07-11T09:02:19-04:00July 11, 2025|Oregon|

Pennsylvania

Gov. Josh Shapiro (D) signed SB 95 into law on July 7. It was effective upon his signature. The law allows for pharmacist licensure by endorsement for 180 days to assist with the increased number of new prescriptions coming into stores due to pharmacy closures in the state. A provisional license application will be posted on the Board of Pharmacy's website soon. NACDS thanks the Pennsylvania Association of Chain Drug Stores (PACDS) for working with members to get this bill across the finish line remarkably quickly during a very challenging budget season. 

Also in Pennsylvania, the long-awaited Pharmacy Technician Registration Regulations were finalized and effective on June 27. 

For more information, contact NACDS’ Jill McCormack at 717-592-8977.

2025-07-11T09:01:25-04:00July 11, 2025|Pennsylvania|
Go to Top